Dr. Jorge Luis Diaz, DO

Dr. Diaz practices at Mirna L. Valencia, M.D., P.A. in Tamarac, Florida.

Dr. Diaz's NPI, 1346279809, was assigned on June 30, 2006. Dr. Diaz graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1996. Dr. Diaz holds Florida license OS7912.

Dr. Diaz's primary practice is Mirna L. Valencia, M.D., P.A., at 9800 W Commercial Blvd, Tamarac, FL 33351 in Broward County. The practice phone is (305) 823-5000.

Dr. Diaz's primary practice is Mirna L. Valencia, M.D., P.A. in Tamarac, Florida. Dmand AI also links Dr. Diaz to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Diaz practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Diaz's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Diaz is board certified in internal medicine by the American Board of Internal Medicine. Dr. Diaz is licensed in Florida.

Dmand AI lists acid reflux, asthma, atrial fibrillation and flutter, bronchitis, chronic anemia, chronic diabetes, chronic hypertension and chronic inflammatory bowel disease (IBD) among the conditions Dr. Diaz treats.

CMS data shows 156 Medicare services from Dr. Diaz across 3 procedure codes in 2024, for 23 Medicare patients. Medicare paid $11,975 for them. Every service was in an office.

CMS counts 23 Medicare patients who saw Dr. Diaz in 2024. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Diaz's median patient age at 58, with 54% women.

In 2024, Dr. Diaz wrote 3,441 Medicare Part D claims for 245 patients. 80% of them were for generic drugs. CMS names the drug for 2,865 of them, across 76 drugs with 11 or more claims each, at $477,679 in total drug cost. In 2023, CMS named 3,606 claims across 80 drugs.

Dr. Diaz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Diaz in 2022. Dr. Diaz's most frequent co-authors are Tom P. Aufderheide, MD, Michael R. Filbin, MD and Jin H. Han, MD, MS.

Dmand AI links Dr. Diaz to 6 clinical trials. Conditions studied include Colitis, Ulcerative, Colitis and Fibromyalgia. Eli Lilly and Company sponsors the most, 3. Open Payments lists research payments to Dr. Diaz that name 5 trials.

CMS Open Payments shows 165 general payments to Dr. Diaz from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 75% of the total. Abbott Laboratories paid the most, $4,737. It also lists 28 research payments totaling $26,380 from 2016 to 2021, naming 5 clinical trials.

Dmand AI lists 1 award for Dr. Diaz, most recently CMS Stage 1 EHR in 2014.

Dr. Diaz graduated from Dr. Kiran C. Patel College of Osteopathic Medicine in 1996.

Dr. Diaz is in network with 15 carriers, including Elevance, Aetna and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.